Biovest International Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Private

  • Employees
  • 51

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $5.6M

Biovest International General Information

Description

Developer of cancer vaccines and biotechnology products. The company develops active personalized immunotherapy that targets cancers of the blood system. It also markets hollow fiber bio-production instruments and provides custom cell-culture services, including contract manufacturing. The company's lead personalized cancer vaccine is BiovaxID, which it is developing as a treatment for late-stage non-Hodgkins lymphoma.

Contact Information

Formerly Known As
Endotronics, Cellex Biosciences Inc
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 8500 Evergreen Boulevard
  • Coon Rapids, MN 55433
  • United States
+1 (763)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 8500 Evergreen Boulevard
  • Coon Rapids, MN 55433
  • United States
+1 (763)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biovest International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. PIPE 15-Jul-2013 $5.6M Completed Bankruptcy: Admin/Reorg
11. Bankruptcy: Admin/Reorg 07-Mar-2013 Completed Bankruptcy: Admin/Reorg
10. Debt - General 24-Feb-2011 Completed Generating Revenue
9. Grant 04-Nov-2010 Completed Generating Revenue
8. Convertible Debt 25-Oct-2010 Completed Generating Revenue
7. Bankruptcy: Admin/Reorg 01-Jan-2009 Completed Generating Revenue
6. Convertible Debt 22-Sep-2008 Completed Bankruptcy: Admin/Reorg
5. PIPE Completed Generating Revenue
4. PIPE 19-Dec-2006 $363K $363K Completed Generating Revenue
3. Buyout/LBO (Add-on) 30-Jun-2003 $20M $1M Completed Generating Revenue
To view Biovest International’s complete valuation and funding history, request access »

Biovest International Patents

Biovest International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150259749-A1 Methods for producing high-fidelity autologous idiotype vaccines Active 31-Aug-2012
US-9725768-B2 Methods for producing high-fidelity autologous idiotype vaccines Active 31-Aug-2012
WO-2014036488-A1 Methods for producing high-fidelity autologous idiotype vaccines Inactive 31-Aug-2012
CA-2920957-A1 Biomanufacturing suite and methods for large-scale production of cells, viruses, and biomolecules Inactive 28-Aug-2012
EP-2909302-A1 Biomanufacturing suite and methods for large-scale production of cells, viruses, and biomolecules Inactive 28-Aug-2012 C12M23/44
To view Biovest International’s complete patent history, request access »

Biovest International Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biovest International FAQs

  • When was Biovest International founded?

    Biovest International was founded in 1993.

  • Where is Biovest International headquartered?

    Biovest International is headquartered in Coon Rapids, MN.

  • What is the size of Biovest International?

    Biovest International has 51 total employees.

  • What industry is Biovest International in?

    Biovest International’s primary industry is Drug Discovery.

  • Is Biovest International a private or public company?

    Biovest International is a Private company.

  • What is Biovest International’s current revenue?

    The current revenue for Biovest International is .

  • How much funding has Biovest International raised over time?

    Biovest International has raised $15.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process